April 27, 2011
DHH Secretary Bruce D. Greenstein and Medicaid Medical Director Dr. Rodney Wise issued the following update to Medicaid providers today regarding the hormone progesterone, commonly known as 17P, which, despite its proven effectiveness in dramatically reducing the risk of a repeat premature birth, has recently been priced at a rate that may keep it out of reach for many Louisiana mothers.